United States Drug Manufacturers - Specialty & Generic news

00:41 28 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Return on assets % of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76

The article provides financial data specifically focusing on the Return on Assets (%) for Ironwood Pharmaceuticals, Inc. Class A, traded under the symbol I76 on the Hamburg Stock Exchange. It indicates historical values and changes for this metric, noting that the market is currently …

IRWD main company

Sharemaestro market context Price above Trend Line 52 weeks +239.4% · Next-week setup positive 56.3%

00:10 28 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

HLN|Haleon PLC|Price:10.280|Chg%:+0.340

This article provides a comprehensive stock analysis of Haleon PLC (HLN), highlighting its healthy fundamentals, high growth potential, and fairly valued status within the Pharmaceuticals industry. It notes high institutional ownership and recent "Buy" ratings from analysts with a target price of $10.63. The …

HLN main company

Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup positive 56.8%

23:55 27 Jul 2026

Stocktwits Deals and strategy Main company 🇺🇸 United States

LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value

Shares of Lantheus Holdings Inc. (LNTH) dropped 3% in after-hours trading following reports that Curium is in advanced talks to acquire the radiopharmaceutical firm for $7 billion. The offer, which includes an upfront payment of roughly $102 per share plus contingent value rights, is …

LNTH main company

Sharemaestro market context Trend signal active 52 weeks +73.4%

23:40 27 Jul 2026

TradingKey Deals and strategy Main company 🇺🇸 United States

BioXcel Therapeutics Inc (BTAI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of BioXcel Therapeutics Inc's (BTAI) dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The article also details several merger-related stock splits scheduled for February 6, 2025, each …

BTAI main company

Sharemaestro market context Price below Trend Line 52 weeks -76.1% · Next-week setup negative 36.4%

23:15 27 Jul 2026

Investing.com UK Market update Main company 🇺🇸 United States

IM Cannabis director Alon Dayan resigns from board By Investing.com

IM Cannabis Corp. announced that director Alon Dayan has resigned from its board for personal reasons. The medical cannabis company, which operates in Israel and Germany, has not yet named a replacement. The company thanked Dayan for his service and is evaluating expansion opportunities …

IMCC main company

Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.2%

23:15 27 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know

Zoetis (ZTS) closed at $76.92 in the latest trading session, marking a +2.08% move from the prior day. This move outpaced the S&P 500's daily gain of 0.02%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased …

ZTS main company

Sharemaestro market context Price below Trend Line 52 weeks -52.3%

22:15 27 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

IM Cannabis (Nasdaq: IMCC) discloses board resignation and corporate update

IM Cannabis Corp. announced the resignation of director Alon Dayan, effective July 26, 2026, citing personal reasons unrelated to company policies. The company, which operates a medical cannabis platform in Israel and Germany, also provided a corporate update on its operations, including importing, distributing, …

IMCC main company

Sharemaestro market context Price below Trend Line 52 weeks -94.7% · Next-week setup negative 39.2%

22:12 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Lifecore Biomedical Inc (LFCR), listing its major individual shareholders and the proportion of shares they hold. It also breaks down shareholder types, such as hedge funds and investment advisors, and provides institutional shareholding data over several quarters, …

LFCR main company

Sharemaestro market context Price below Trend Line 52 weeks -37.9%

22:11 27 Jul 2026

Seeking Alpha Deals and strategy Main company 🇺🇸 United States

Curium in talks to buy Lantheus Holdings for about $7B - Bloomberg (LNTH:NASDAQ)

Curium, backed by CapVest Partners, is reportedly in advanced discussions to acquire radiopharma company Lantheus Holdings (LNTH) for approximately $7 billion. The deal is expected to be announced soon, with Curium offering an upfront payment of around $102 per share and an additional $12.50 …

LNTH main company

Sharemaestro market context Trend signal active 52 weeks +73.4%

22:11 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown of SCYNEXIS Inc (SCYX) by business segments and regions. However, it states that relevant data for these categories have not yet been disclosed by the company. The page provides current stock information for SCYNEXIS Inc, including its market …

SCYX main company

Sharemaestro market context Price below Trend Line 52 weeks -20.6% · Next-week setup negative 38.7%

22:11 27 Jul 2026

Moomoo Earnings Main company 🇺🇸 United States

Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says

UBS analysts believe Elanco is the animal health stock best positioned going into Q2 earnings, driven by strong companion animal growth, favorable comparisons, and new product opportunities like Credelio Quattro and potentially Zeneta. While Zoetis faces tough comps and likely flat growth in companion …

ELAN main company

Sharemaestro market context Price below Trend Line 52 weeks +32.2%

22:10 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Viatris Inc.'s (VTRS) shareholder structure, listing major shareholders and their proportionate holdings, along with institutional ownership trends over recent quarters. It also categorizes shareholders by type and lists ETFs with significant VTRS holdings.

VTRS main company

Sharemaestro market context Trend signal active 52 weeks +56.5%

22:10 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Emergent BioSolutions Inc (EBS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Emergent BioSolutions Inc (EBS), noting its current valuation score of 9.29 and ranking within the Pharmaceuticals industry. It highlights the company's P/E ratio and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet …

EBS main company

Sharemaestro market context Price below Trend Line 52 weeks -50.3% · Next-week setup negative 43.4%

21:46 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Perrigo Company PLC (PRGO) Income Statement

This article presents the quarterly and annual income statements for Perrigo Company PLC (PRGO), offering detailed financial data including total revenue, cost of revenue, operating expenses, and net income over several years. It provides investors with insights into the company's financial performance and operational …

PRGO main company

Sharemaestro market context Price above Trend Line 52 weeks -42.2%

21:42 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Akebia Therapeutics Inc (AKBA) Income Statement

This article provides the quarterly and annual income statement for Akebia Therapeutics Inc (AKBA), offering detailed financial data such as total revenue, operating expenses, special income, and net income stretching back to FY2012Q4. It highlights the company's financial performance, including a fiscal year 2025 …

AKBA main company

Sharemaestro market context Price below Trend Line 52 weeks -72.6%

21:42 27 Jul 2026

Yahoo! Finance Canada Earnings Main company 🇺🇸 United States

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

This article analyzes the Q1 performance of branded pharmaceutical stocks, highlighting Collegium Pharmaceutical as a key example. It discusses industry tailwinds like precision medicine and AI adoption, alongside headwinds such as regulatory scrutiny and patent cliffs. While Collegium Pharmaceutical's revenue beat expectations, its full-year …

COLL main company

Sharemaestro market context Price below Trend Line 52 weeks -27.8%

21:40 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of ANI Pharmaceuticals Inc (ANIP), listing its major shareholders and their respective proportions. It also provides a breakdown of shareholder types by proportion and presents institutional shareholding trends over several quarters, including changes in the number of institutions …

ANIP main company

Sharemaestro market context Price below Trend Line 52 weeks -15.9%

21:40 27 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

BlackRock (ANIP) discloses 2.9M-share, 12.8% stake in ANI Pharmaceuticals

BlackRock, Inc. has filed an amended beneficial ownership report, disclosing a 12.8% stake in ANI Pharmaceuticals Inc. (ANIP). BlackRock's business units collectively beneficially own 2,899,843 shares of ANI Pharmaceuticals common stock, with sole voting power over 2,860,943 shares and sole dispositive power over all …

ANIP main company

Sharemaestro market context Price below Trend Line 52 weeks -15.9%

21:39 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Collegium Pharmaceutical Inc

This article provides a detailed revenue breakdown for Collegium Pharmaceutical Inc. (COLL) by business segment and geographical region. It highlights major product contributions like Nucynta IR, Belbuca, and Xtampza ER, and notes that all revenue is generated within the United States. Key financial metrics …

COLL main company

Sharemaestro market context Price below Trend Line 52 weeks -27.8%

21:11 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Sonoma Pharmaceuticals Inc (SNOA) Institutional Confidence

This article provides an overview of Sonoma Pharmaceuticals Inc. (SNOA) institutional confidence score and shareholder activity as of July 27, 2026. DRW Securities, LLC notably increased its shares held by 257.22%, while other institutions like Geode Capital Management and Global Retirement Partners also reported …

SNOA main company

Sharemaestro market context Price below Trend Line 52 weeks -74.5% · Next-week setup negative 43.9%

21:09 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Gelteq Ltd (GELS), detailing various metrics related to volatility, financial risk, and investment risk. It includes data such as maximum drawdown, realized volatility, return-to-drawdown ratio, and liquidity metrics over different timeframes. The assessment aims to offer insights …

GELS main company

Sharemaestro market context Price below Trend Line 52 weeks -55.0% · Next-week setup negative 42.9%

20:41 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

BioXcel Therapeutics Inc (BTAI) Income Statement

This article provides an income statement for BioXcel Therapeutics Inc (BTAI), presenting detailed quarterly and annual financial data spanning several years. It includes key metrics such as total revenue, operating expenses, R&D expenses, operating profit, and net income, alongside basic and diluted earnings per …

BTAI main company

Sharemaestro market context Price below Trend Line 52 weeks -76.1% · Next-week setup negative 36.4%

20:40 27 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

BioXcel Therapeutics, Inc. Revenue Breakdown – MUN:BX20

BioXcel Therapeutics, Inc. (MUN:BX20) generated 546.61K EUR in revenue last year, primarily from its Medicines segment, a decrease from 2.19M EUR in the previous year. The United States was the company's largest contributor to revenue, accounting for the entire 546.61K EUR.

BTAI main company

Sharemaestro market context Price below Trend Line 52 weeks -76.1% · Next-week setup negative 36.4%

20:19 27 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Viatris stock hits 52-week high at $17.68

Viatris Inc. (VTRS) stock reached a 52-week high of $17.68, reflecting strong market performance with a 90.82% surge over the past year and a 2.78% dividend yield. The pharmaceutical company is considered undervalued by InvestingPro, with recent positive news including exceeding Q1 2026 financial …

VTRS main company

Sharemaestro market context Trend signal active 52 weeks +56.5%

20:17 27 Jul 2026

The Manila Times Earnings Main company 🇺🇸 United States

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Harrow will report its second-quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will also host a conference call and live webcast on Tuesday, August 11, 2026, at 8:00 a.m. Eastern Time to discuss the results and provide …

HROW main company

Sharemaestro market context Price above Trend Line 52 weeks +2.3% · Next-week setup positive 56.7%

20:12 27 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Haleon PLC Sponsored ADR Revenue Breakdown – HAM:H6D

Haleon PLC Sponsored ADR (HAM:H6D) generated 12.71 billion EUR in revenue last year. The Oral Health segment was its top-performing division, contributing 3.88 billion EUR, while the EMEA and Latin America region provided the greatest geographical contribution at 5.15 billion EUR. This information highlights …

HLN main company

Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup positive 56.8%

20:11 27 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Net margin % of Neurocrine Biosciences, Inc. – HAM:NB3

This page from TradingView provides financial information for Neurocrine Biosciences, Inc. (HAM:NB3), specifically focusing on its net margin percentage. It details market performance on the Hamburg Stock Exchange and offers tools for financial analysis. The content primarily lists product offerings and company information related …

NBIX main company

Sharemaestro market context Trend signal active 52 weeks +12.8% · Next-week setup positive 56.9%

20:11 27 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Bausch Health Companies Inc expected to post earnings of $1.01 a share - Earnings Preview

Bausch Health Companies Inc. is projected to report earnings of $1.01 per share. This information comes from an earnings preview provided by Refinitiv. The article provides a headline and directs readers to TradingView for the full article.

BHC main company

Sharemaestro market context Price above Trend Line 52 weeks -13.1%

20:10 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

BioCryst Pharmaceuticals Inc (BCRX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of BioCryst Pharmaceuticals Inc (BCRX), noting its current valuation score of 8.70, ranking 95th in its industry. It highlights the company's P/E ratio of -5.56 and states that relevant data for P/B, P/S, and P/CF ratios have not …

BCRX main company

Sharemaestro market context Trend signal active 52 weeks +13.8%

19:41 27 Jul 2026

Benzinga España Earnings Main company 🇺🇸 United States

Aytu BioPharma Market Sentiment

This article analyzes market sentiment for Aytu BioPharma (AYTU), covering analyst consensus, short interest, options flow, and insider activity. Analysts currently have a "Buy" consensus with an average price target significantly above the current stock price, and there's a declining short interest. Recent insider …

AYTU main company

Sharemaestro market context Price below Trend Line 52 weeks +8.2% · Next-week setup negative 37.8%

19:40 27 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Aquestive Therapeutics Inc (AQST) Institutional Confidence

Aquestive Therapeutics Inc (AQST) has an institutional shareholding score of 5.00, placing it 72nd within the Pharmaceuticals industry. Institutional investors collectively hold 60.30% of the shares, marking a 16.75% increase quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 912.50K shares.

AQST main company

Sharemaestro market context Price above Trend Line 52 weeks +6.8%

19:40 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

ANIK|Anika Therapeutics Inc|Price:15.200|Chg%:+0.180

This article provides a comprehensive stock analysis of Anika Therapeutics Inc (ANIK) by TradingKey. It highlights the company's strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. The analysis also notes high institutional ownership and a "Strong Buy" …

ANIK main company

Sharemaestro market context Trend signal active 52 weeks +122.8%

19:40 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Amylyx Pharmaceuticals Inc (AMLX) Cash Flow

This article provides a detailed cash flow statement for Amylyx Pharmaceuticals Inc (AMLX), covering quarterly and annual data from FY2020Q4 to FY2026Q1 across operating, investing, and financing activities. It presents financial figures in USD, highlighting net income, capital expenditures, and changes in working capital. …

AMLX main company

Sharemaestro market context Trend signal active 52 weeks +132.6% · Next-week setup positive 55.7%

19:10 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Amylyx Pharmaceuticals Inc (AMLX) Valuation: PE, PB & Fair Value Analysis

Amylyx Pharmaceuticals Inc (AMLX) has a current valuation score of 8.13, placing it 163rd out of 386 in the Biotechnology & Medical Research industry. Its P/E ratio stands at -13.13, which is significantly below its recent high but above its recent low. The company …

AMLX main company

Sharemaestro market context Trend signal active 52 weeks +132.6% · Next-week setup positive 55.7%

18:43 27 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

Redhill Biopharma Ltd (RDHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses Redhill Biopharma Ltd (RDHL) revenue breakdown but states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. It provides current stock information, including the price, market cap, and P/E TTM. The …

RDHL main company

Sharemaestro market context Price below Trend Line 52 weeks -54.2% · Next-week setup negative 35.9%

18:40 27 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Total operating expenses of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76

This article states the total operating expenses for Ironwood Pharmaceuticals, Inc. Class A, traded on the Hamburg Stock Exchange under the ticker I76. It indicates that the market is closed with no current trades. Further financial details would be available in a dedicated "Financials" …

IRWD main company

Sharemaestro market context Price above Trend Line 52 weeks +239.4% · Next-week setup positive 56.3%